According to a STAT investigation, IBM Watson’s deployment in a hospital setting has mostly fallen short of expectations for cancer care.
“(Watson) is still struggling with the basic step of learning about different forms of cancer,” STAT reports. ” … And at foreign hospitals, physicians complained its advice is biased toward American patients and methods of care.”
According to STAT, some of Watson’s greatest flaws have so far been discovered in real time environments by doctors and researchers.
“Watson for Oncology is in their toddler stage, and we have to wait and actively engage, hopefully to help them grow healthy,” South Korean cancer specialist Dr. Taewoo Kang told STAT.
IBM executives say Watson for Oncology is still in its infancy, but that it continues to improve.
“We’re seeing stories come in where patients are saying, ‘It gave me peace of mind,'” Deborah DiSanzo, Watson Health general manager, said. “That makes us feel extraordinarily good that what we’re doing is going to make a difference for the patients and their physicians.”